BASF sells drug ingredient businesses Siegfried €270 million

BASF sells drug ingredient businesses to Siegfried for €270 million

7:45 AM, 8th May 2015
BASF sells drug ingredient businesses to Siegfried for €270 million
Michael Heinz, executive directors board member, BASF SE and also responsible for performance products segment.

LUDWIGSHAFEN, GERMANY: The world’s largest chemical company BASF SE said it will sell parts of its pharmaceutical ingredients business to drug contract manufacturer Siegfried Holding AG for an enterprise value of approximately €270 million.

The company plans to focus its pharmaceutical ingredients & services business on its core expertise in pharmaceutical excipients. Leading excipient portfolio and selected APIs, such as ibuprofen, omega-3 fatty acids and polyethylenglycol (PEG), where the company has a leading market position, will remain part of BASF’s portfolio, it said.

All employees, about 850 positions globally, affected from the transaction are to be transferred to the acquiring company, it said. The transaction comprises the divestment of BASF’s production sites in Minden, Germany; Evionnaz, Switzerland; and Saint-Vulbas, France.

“This step is in line with BASF’s strategy of actively managing its portfolio and it will further sharpen the focus of the performance products segment on growth and high margin core businesses,” said Michael Heinz, executive directors board member, BASF SE and also responsible for performance products segment.

“With this divestiture, we are focusing our portfolio on strategic growth areas in the pharmaceutical industry,” said Saori Dubourg, president of BASF’s nutrition & health division.

“Through this acquisition, Siegfried will reach the critical size to play a leading role in the supplier market as a recognized partner for the pharmaceutical industry. This acquisition demonstrates the growth potential for the Siegfried Group,” said Dr Rudolf Hanko, CEO, Siegfried.

BASF will provide transitional services to ensure a smooth and seamless business transfer for both customers and employees, it said.

© Worldofchemicals News 



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

IFF elects former Ernst & Young, global COO, Ferraro to its board

NEW YORK, US: International Flavors & Fragrances Inc (IFF) said it has elected former global chief operating officer of Ernst & Young, John Fe ...

Read more
Biesterfeld appoints Peter Wilkes as managing director

HAMBURG, GERMANY: Chemical distributor Biesterfeld Spezialchemie GmbH said it has appointed Peter Wilkes as managing director, succeeding Thomas Arnol ...

Read more
Fluor consortium gets natural gas project EPC contract in Brazil

IRVING, US/SAO PAULO, BRAZIL: Engineering company Fluor Corporation said it’s Brazil unit was part of a consortium that was awarded a contract b ...

Read more
Momentive appoints GrafTech executive Asmussen as CFO

WATERFORD, US: Maker of silicones and quartz products Momentive Performance Materials Inc said it has named GrafTech International Ltd, CFO, Erick Asm ...

Read more
Novozymes to supply enzymes for new St1 Biofuels bio-refinery

BAGSVAERD, DENMARK: Biotech company Novozymes A/S said it will supply enzyme technology to a new bio-refinery to be built by St1 Biofuels Oy in Kajaan ...

Read more
A. Schulman to move European shared service centre to Poland

AKRON, US: A. Schulman Inc said it plans to move its Europe, Middle East and Africa (EMEA) shared service centre to Poznan, Poland from Londerzeel, Be ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X